$210 million endowment from entrepreneur and Moderna investor Tim Springer will support ongoing research
A founding investor in the biotechnology company Moderna has donated $210 million (£170 million) to the Institute for Protein Innovation (IPI) in Boston, US.
Billionaire Tim Springer, who has been a professor of biological chemistry and molecular pharmacology at Harvard Medical School for 46 years, cofounded the IPI in 2017 and previously donated $40 million to the non-profit research organisation.